ADALIMUMAB-AATY

adalimumab · CELLTRION USA, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ADALIMUMAB-AATY, covering 2023-05-23 to 2025-04-07. Get the full timeline:

Most recent: FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)